European Animal Vaccine Market to Reach $6,873.7 million in 2035, Growing at 6.3% CAGR

European Animal vaccine market valued at $3,731.4 million in 2025 and is projected to reach $6,873.7 million by 2035, growing at a CAGR of 6.3% during the forecast period (2026-2035). The market comprises preventive biological products developed for livestock and companion animals to control infectious diseases and improve herd health management. The market is witnessing steady growth supported by rising incidences of transboundary and zoonotic diseases such as African swine fever, avian influenza, and bluetongue across multiple European countries. Expanding livestock production efficiency programs and stringent animal health regulations under the European Union Animal Health Law are reinforcing vaccination as a primary disease-control strategy. In addition, the growing companion animal population across Western Europe is accelerating demand for advanced recombinant and multivalent vaccines for pets. Technological advancements, including recombinant and vector-based vaccine platforms, are enabling improved efficacy and safety profiles. Increasing R&D investments by major veterinary pharmaceutical companies and rising government-supported animal disease surveillance programs further support long-term market expansion.

Browse the full report description of “European Animal Vaccine Market Size, Share & Trends Analysis Report by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/european-animal-vaccine-market

According to the European Medicines Agency and the European Commission, Europe maintains one of the most comprehensive veterinary regulatory and pharmacovigilance frameworks globally. Data-driven monitoring of animal populations, vaccination coverage, and outbreak surveillance strengthens procurement planning and ensures sustained demand for animal vaccines across the region.

Key Statistics: European Animal Vaccines at a Glance

• Europe accounts for approximately 28–30% of the global animal vaccine market revenue, making it one of the leading regional markets globally
• The European livestock population exceeds 300 million cattle, pigs, and small ruminants combined, representing a substantial addressable base for porcine and livestock vaccines.
• Companion animal ownership in Europe surpasses 340 million pets, significantly supporting growth in canine and feline vaccination programs.
• Poultry production in Europe exceeds 13 billion birds annually, driving consistent demand for large-scale immunization programs in commercial poultry farming.

Key Innovators Driving European Animal Vaccine Transformation

The key players in the European animal vaccine market include Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Hester Biosciences Limited, Merck & Co., Inc., Zoetis Inc, among others.

• In June 2025, Zoetis expanded its swine vaccine portfolio in Europe with updated formulations targeting respiratory and reproductive diseases in pigs, increasing its presence in the regional porcine vaccine segment.
• In April 2025, Boehringer Ingelheim introduced a recombinant poultry vaccine in several European markets. The product is intended to support immunization programs and address disease-related productivity losses in commercial poultry operations.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Technology
• Competitive Landscape - Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Hester Biosciences Limited, Merck & Co., Inc., Zoetis Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

European Animal Vaccine Market Report Segment

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Aquaculture Vaccines
• Companion Animal Vaccines
• Other

By Technology

• Live Attenuated Vaccine
• Killed/Inactive Vaccine
• Recombinant Vaccine
• Vectored Vaccine
• Subunit Vaccine
• DNA Vaccine
• Chimeric Vaccine
• Others

European Animal Vaccine Market Report Segment by Region

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-animal-vaccine-market